Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Leap Therapeutics Inc’s current trading price is -91.91% away from its 52-week high, while its distance from the 52-week low is 74.31%. The stock’s price range during this period has varied between $0.22 and $4.79. The company, active in the Healthcare sector, saw a trading volume of around 48.37 million for the day, considerably higher average daily volume of 2.16 million observed over the last three months.
Leap Therapeutics Inc’s stock has seen a rocky market performance.
How Financial Performance Impacts Market Capitalization
Leap Therapeutics Inc (LPTX) has experienced a quarterly decline of -3.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 16.06M and boasts a workforce of 52 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
How LPTX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for LPTX stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.00.
LPTX Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -80.03%. However, over the past six months, we’ve seen a stronger performance of -87.54%. The price of LPTX fallen by 7.22% over the last 30 days. And in the last five days, it has fallen by -5.46%.
